CGNX.NASDAQCognex CORP

Form 4: Cognex CTO Boosts Holdings with RSU Vesting and New Grant

Sentiment:

Insider Transaction Report


Cognex Corporation's Chief Technology Officer, Joerg Kuechen, reported the vesting of restricted stock units and a new RSU grant, increasing his direct beneficial ownership.

Summary

  • Joerg Kuechen, Chief Technology Officer of Cognex Corporation (CGNX), reported transactions related to his equity compensation.
  • On February 18, 2026, 4,056 shares of Common Stock were acquired due to the vesting of restricted stock units (RSUs).
  • Concurrently, 1,327 shares of Common Stock were disposed of at a price of $56.72 per share to satisfy tax withholding obligations related to the RSU vesting.
  • Following these transactions, Kuechen directly beneficially owns 2,729 shares of Common Stock.
  • A new grant of 8,759 Restricted Stock Units (RSUs) was made on February 17, 2026, which will vest 100% on February 17, 2028.
  • Kuechen also holds various non-qualified stock options with exercise prices ranging from $33.04 to $90.50 and expiration dates extending to February 18, 2035.
  • Total derivative securities beneficially owned, including RSUs and stock options, amount to 498,447 units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting routine executive compensation and an increase in the CTO's direct equity holdings, which generally signals management's continued alignment with shareholder interests.

Positives

  • The Chief Technology Officer received a new grant of 8,759 Restricted Stock Units, indicating ongoing compensation and retention.
  • 4,056 shares of Common Stock vested from previous RSU grants, increasing the officer's direct equity ownership after tax withholding.
  • The officer's continued accumulation of equity through grants and vesting aligns management interests with shareholder value.

Negatives

  • A portion of vested shares (1,327 shares) was sold to cover tax withholding obligations, which is a standard practice but reduces the immediate increase in direct share ownership.

Future Outlook

The filing indicates future vesting events for Restricted Stock Units, with 8,759 RSUs vesting 100% on February 17, 2028, and remaining tranches of a prior RSU grant vesting on February 18, 2027, and February 18, 2028. This outlines a continued schedule of equity compensation for the Chief Technology Officer.

Industry Context

StockSavvy.ai notes that equity compensation, particularly through Restricted Stock Units and stock options, is a common practice in the technology and industrial automation sectors, aligning executive incentives with long-term company performance. Cognex, a leader in machine vision, uses these mechanisms to retain key talent like its CTO, which is consistent with industry standards for attracting and motivating high-level technical leadership.

Comparison to Industry Standards

  • The use of Restricted Stock Units (RSUs) and Non-Qualified Stock Options (NQSOs) for executive compensation is a standard practice across the technology and industrial automation industries, comparable to compensation structures at companies like Keyence, Rockwell Automation, and Siemens.
  • The vesting schedules, such as the 100% vesting on the second anniversary for new RSU grants and multi-year staggered vesting for others, are typical for executive retention and performance incentives in the sector.
  • The disposition of shares for tax withholding upon RSU vesting is a routine and expected event, reflecting standard tax compliance for equity compensation, similar to practices observed at peer companies.

Stakeholder Impact

  • Shareholders: The increase in the Chief Technology Officer's direct share ownership, even after tax withholding, indicates continued alignment of management's interests with shareholder value.
  • Employees (specifically the CTO): The RSU grant and vesting represent ongoing compensation and incentives, contributing to executive retention and motivation.

Next Steps

  • The 8,759 Restricted Stock Units granted on February 17, 2026, are scheduled to vest 100% on February 17, 2028.
  • Remaining tranches of a prior RSU grant are expected to vest on February 18, 2027, and February 18, 2028.
  • The reporting person continues to hold various non-qualified stock options with future exercise opportunities until their respective expiration dates.

Key Dates

DateDescription
02/21/2018Grant date for 12,500 Non-Qualified Stock Options.
02/20/2019Grant date for 30,000 Non-Qualified Stock Options.
02/19/2020Grant date for 45,000 Non-Qualified Stock Options.
02/18/2021Grant date for 80,000 Non-Qualified Stock Options.
02/16/2022Grant date for 29,486 Non-Qualified Stock Options.
02/22/2023Grant date for 49,530 Non-Qualified Stock Options.
02/21/2024Grant date for 67,759 Non-Qualified Stock Options and 6,355 Restricted Stock Units.
02/18/2025Grant date for a Restricted Stock Unit award, with approximately 20% vesting on this date's first anniversary.
02/20/2025Grant date for 89,103 Non-Qualified Stock Options and 14,199 Restricted Stock Units.
02/17/2026Grant date for 8,759 Restricted Stock Units, vesting 100% on the second anniversary.
02/18/2026Transaction date for the acquisition of 4,056 Common Stock shares from RSU vesting and disposition of 1,327 shares for tax withholding. This is the second anniversary of a RSU grant, where approximately 30% vested.
02/19/2026Signature date of the reporting person.
02/21/2026Vesting date for 6,355 Restricted Stock Units granted on 02/21/2024.
08/04/2026Grant date for 39,894 Non-Qualified Stock Options.
02/21/2027Expiration date for 12,500 Non-Qualified Stock Options. Vesting date for 14,199 Restricted Stock Units granted on 02/20/2025. Third anniversary of a RSU grant, where approximately 50% vested.
02/17/2028Vesting date for 8,759 Restricted Stock Units granted on 02/17/2026.
02/18/2028Final vesting date for a Restricted Stock Unit grant made on 02/18/2025.
02/20/2028Expiration date for 30,000 Non-Qualified Stock Options.
02/19/2029Expiration date for 45,000 Non-Qualified Stock Options.
02/18/2030Expiration date for 80,000 Non-Qualified Stock Options.
02/16/2031Expiration date for 29,486 Non-Qualified Stock Options.
02/22/2032Expiration date for 49,530 Non-Qualified Stock Options.
08/04/2032Expiration date for 39,894 Non-Qualified Stock Options.
02/21/2033Expiration date for 67,759 Non-Qualified Stock Options.
02/20/2034Expiration date for 89,103 Non-Qualified Stock Options.
02/18/2035Expiration date for 55,141 Non-Qualified Stock Options.

Recommendation

hold

This Form 4 filing primarily details routine insider compensation activities (RSU vesting and new grants) for the Chief Technology Officer. While the increase in direct share ownership after tax withholding is a positive signal of management alignment, it does not provide new fundamental information about the company's operational performance or strategic direction that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

Cognex, CGNX, Insider Transaction, Form 4, Restricted Stock Units, Stock Options, Equity Compensation, Chief Technology Officer, Joerg Kuechen

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.